Atlas Trials

Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

Clinical trial NCT07038213 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07038213
Sponsor
Astana Medical University
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Diabetes MellitusDiabetic Nephropathy
Start date
2025-07-19
Primary completion
2026-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.